(Q36606351)

15 August 2017

7 references

24 March 2019

22 April 2019

19 June 2019

25 June 2019

23 July 2019

19 September 2019

15 July 2021

The impact of iron overload and its treatment on quality of life: results from a literature review (English)

1 reference

biomedical investigative technique

15 August 2017

7 references

24 March 2019

22 April 2019

19 June 2019

25 June 2019

23 July 2019

19 September 2019

15 July 2021

1 reference

19 September 2019

2 references

23 July 2019

sickness impact profile

1 reference

15 July 2021

Linda Abetz

1

1 reference

15 August 2017

Jean-Francois Baladi

series ordinal

2

1 reference

15 August 2017

Paula Jones

series ordinal

3

1 reference

15 August 2017

Diana Rofail

series ordinal

4

1 reference

15 August 2017

language of work or name

1 reference

28 September 2006

8 references

Health and Quality of Life Outcomes

15 August 2017

24 March 2019

22 April 2019

19 June 2019

25 June 2019

23 July 2019

19 September 2019

15 July 2021

8 references

15 August 2017

24 March 2019

22 April 2019

19 June 2019

25 June 2019

23 July 2019

19 September 2019

15 July 2021

4

1 reference

15 August 2017

73

1 reference

Creative Commons Attribution 2.0 Generic

15 August 2017

7 references

24 March 2019

22 April 2019

19 June 2019

25 June 2019

23 July 2019

19 September 2019

on focus list of Wikimedia project

15 July 2021

copyright status

copyrighted

0 references

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Quality of life in patients with thalassemia intermedia compared to thalassemia major

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Quality of life in thalassemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Parental report of health-related quality of life in children with sickle cell disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Chelation therapy in beta-thalassemia: an optimistic update

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Deferoxamine pharmacokinetics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Pain, quality of life, and coping in sickle cell disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Results of long-term iron-chelating therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Clinical manifestations and therapy of transfusional haemosiderosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Psychosocial and clinical burden of thalassaemia intermedia and its implications for prenatal diagnosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Beta-thalassaemia--the Johannesburg experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Transfusion reactions in thalassemia. A survey from the Cooleycare programme. The Cooleycare Cooperative Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Beta thalassaemia in Papua New Guinea

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiprone

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Depression in sickle cell disease

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Impact of thalassemia major on patients and their families

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Pharmacosurveillance and quality of care of thalassaemic patients. A large scale epidemiological survey

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1592476

Psychological distress and coping in sickle cell disease: comparison of British and Jamaican attitudes

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17007645

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The psychosocial experience of people with sickle cell disease and its impact on quality of life: Qualitative findings from focus groups

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17007645

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sickle cell disease: Pain, coping and quality of life in a study of adults in the UK

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17007645

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1477-7525-4-73

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

17007645

1 reference